| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/18/1997 | EP0778891A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
| 06/18/1997 | EP0778890A1 Dna encoding a human calcium channel alpha-1e subunit |
| 06/18/1997 | EP0778889A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 06/18/1997 | EP0778888A1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/18/1997 | EP0778884A1 Production and secretion of recombinant fibrinogen by yeast |
| 06/18/1997 | EP0778849A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/18/1997 | EP0778781A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 06/18/1997 | EP0778777A1 A method of sequencing proteins by epitope ordering and protein restriction mapping |
| 06/18/1997 | EP0778727A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
| 06/18/1997 | EP0710110A4 Rapamycin conjugates and antibodies |
| 06/18/1997 | EP0674712A4 A proteinase inhibitor, precursor thereof and genetic sequences encoding same. |
| 06/18/1997 | EP0674697B1 Foodstuffs and other compositions |
| 06/18/1997 | EP0610330B1 Monoclonal antibodies directed against the microtubule-associated protein tau |
| 06/18/1997 | EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor |
| 06/18/1997 | EP0447483B1 Dopamine receptors and genes |
| 06/18/1997 | CN1152338A Streptogramines and method for preparing same by mutasynthesis |
| 06/18/1997 | CN1152337A Superoxide dismutase-4 |
| 06/18/1997 | CN1152315A Monocyte chemotactic protein-4 |
| 06/17/1997 | US5639949 Genes for the synthesis of antipathogenic substances |
| 06/17/1997 | US5639947 Genetic engineering |
| 06/17/1997 | US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development |
| 06/17/1997 | US5639863 Isolated dna which codes for a variable region of the antibody which is active against glioma antigen |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639855 Adrenomedullin |
| 06/17/1997 | US5639853 Respiratory syncytial virus vaccines |
| 06/17/1997 | US5639728 Antineoplastic peptide |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639664 A transformant; genetic engineering |
| 06/17/1997 | US5639656 Antibodies reactive with biological markers of benign prostate hyperplasia |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639642 Synthetic leader peptide sequences |
| 06/17/1997 | US5639641 Resurfacing of rodent antibodies |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639635 Process for bacterial production of polypeptides |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639621 Immunoreactive with a polymorphic epithelial mucin antigen |
| 06/17/1997 | US5639619 Screening assay for anti-HIV drugs using the Vpr gene |
| 06/17/1997 | US5639617 Determining concentration of procalcitonin in biological fluids to diagnose infections or monitor treatment |
| 06/17/1997 | US5639597 Specific, sensitive |
| 06/17/1997 | US5639457 Introducing dna sequence coding for rearranged antibody into male pronucleus of fertilized ovum; implanting in pig or rabbit; transgenic offspring produce antibodies |
| 06/17/1997 | US5639455 Immunosuppressant |
| 06/17/1997 | US5639453 Therapeutic uses of IL-3 |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997020945A1 Process for the preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms |
| 06/12/1997 | WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | WO1997020857A1 Cyclic dodecapeptide and process for the preparation thereof |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | DE19547529A1 New monoclonal antibody specific for membrane antigen on colon carcinoma |
| 06/12/1997 | DE19545639A1 Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen A process for the preparation of substituted Arylmilchsäure-containing cyclodepsipeptides having 24 ring atoms |
| 06/12/1997 | DE19545463A1 Organisch-chemische Verbindung und Verfahren zu ihrer Herstellung Organic chemical compound and processes for their preparation |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/11/1997 | EP0778348A1 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 06/11/1997 | EP0777859A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 06/11/1997 | EP0777748A1 Peptide librairies as a source of syngenes |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777737A1 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| 06/11/1997 | EP0777734A2 New polypetides having a toxic activity against insects of the dipter family |
| 06/11/1997 | EP0777733A1 Method of treating birds with avian myelomonocytic growth factor |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777690A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 06/11/1997 | EP0777688A1 New immunocontraceptive peptides |
| 06/11/1997 | EP0777687A1 Trefoil peptide dimer |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777685A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777683A1 Antiprotozoal cyclic tetrapeptides |
| 06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777490A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 06/11/1997 | EP0777489A1 Low molecular yeast active substance extract and process for preparing the same |
| 06/11/1997 | EP0607186B1 Macrophage activating factor from animal vitamin d-binding protein |
| 06/11/1997 | EP0472706B1 Induction of protection against viral infection |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
| 06/11/1997 | CN1151762A Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| 06/11/1997 | CN1151760A Serum paraoxonase |
| 06/11/1997 | CN1151759A Antibodies which bind to insect jut proteins and their use |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
| 06/10/1997 | US5637569 Ganglioside analogs |
| 06/10/1997 | US5637567 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties |
| 06/10/1997 | US5637561 Removing glucose molecule from glucones in presence at least one glucosidase, esterase enzymes |